$171 Million is the total value of Knoll Capital Management, LLC's 33 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 66.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BX | Sell | Blackstone Group LP | $838,000 | -42.6% | 10,000 | -37.5% | 0.49% | -41.2% |
| EIGR | Sell | Eiger Biopharmaceuticals Inc | $586,000 | -86.6% | 585,966 | -15.6% | 0.34% | -86.3% |
| ABEO | Sell | Abeona Therapeutics Inc | $269,000 | -41.6% | 88,629 | -96.0% | 0.16% | -40.3% |
| SNGX | Sell | Soligenix Inc. | $15,000 | -90.8% | 34,766 | -87.2% | 0.01% | -90.3% |
| SPRO | Exit | Spero Therapeutics Inc | $0 | – | -70,000 | -100.0% | -0.03% | – |
| ANGN | Exit | Angion BioMedica Corp | $0 | – | -60,000 | -100.0% | -0.04% | – |
| AGTC | Exit | Applied Genetic Technologies | $0 | – | -100,000 | -100.0% | -0.04% | – |
| ASML | Exit | ASML Holdings | $0 | – | -1,280 | -100.0% | -0.35% | – |
| AMD | Exit | Advanced Micro Devices Inc | $0 | – | -8,200 | -100.0% | -0.36% | – |
| OSK | Exit | OSHKOSH CORP | $0 | – | -8,450 | -100.0% | -0.40% | – |
| LUMN | Exit | Lumen Technologies Inc | $0 | – | -100,000 | -100.0% | -0.62% | – |
| ANET | Exit | Arista Networks Inc | $0 | – | -13,800 | -100.0% | -0.74% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Aldeyra Therapeutics Inc | 35 | Q3 2023 | 31.6% |
| Corbus Pharmaceuticals HLDGS | 30 | Q3 2022 | 46.5% |
| Abeona Therapeutics Inc | 30 | Q3 2022 | 34.8% |
| Biohaven Pharmactl Hldg Co L | 26 | Q3 2023 | 79.6% |
| Entera Bio Ltd | 22 | Q3 2023 | 7.8% |
| Ampio Pharmaceuticals Inc. | 21 | Q2 2018 | 11.0% |
| Soligenix Inc. | 20 | Q3 2022 | 1.7% |
| Eiger Biopharmaceuticals Inc | 19 | Q3 2022 | 5.8% |
| Applied Therapeutics Inc | 18 | Q3 2023 | 19.7% |
| Alcobra Ltd | 18 | Q3 2017 | 6.5% |
View Knoll Capital Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| HOOKIPA Pharma Inc. | June 20, 2023 | 5,517,385 | 6.8% |
| Applied Therapeutics Inc. | January 23, 2023 | 3,450,000 | 7.2% |
| Orgenesis Inc. | August 14, 2020 | 1,316,364 | 5.9% |
| Corbus Pharmaceuticals Holdings, Inc. | February 14, 2020 | 5,045,870 | 7.1% |
| ABEONA THERAPEUTICS INC. | February 14, 2018 | 2,359,767 | 5.0% |
| SOLIGENIX, INC. | November 13, 2017 | 870,000 | 9.9% |
| ABEONA THERAPEUTICS INC. | February 14, 2017 | 2,359,767 | 5.9% |
| ALCOBRA LTD. | February 14, 2017 | 1,205,498 | 4.4% |
| Ampio Pharmaceuticals, Inc. | February 14, 2017 | 2,738,322 | 4.8% |
| RITTER PHARMACEUTICALS INC | February 14, 2017 | 952,434 | 8.2% |
View Knoll Capital Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-01-16 |
| 13F-HR | 2023-11-14 |
| SC 13G | 2023-10-04 |
| 13F-HR | 2023-08-15 |
| SC 13G | 2023-06-20 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| SC 13G | 2023-01-23 |
| 13F-HR | 2022-11-14 |
View Knoll Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.